Post by UCLA Anderson Center for Healthcare Innovation

Hope for one of the deadliest forms of brain cancer may be on the horizon. 🧠 Researchers at UCLA Health, led by David Nathanson, are developing a targeted therapy designed specifically for glioblastoma — a cancer that has long resisted treatment. The team created KTM-101, a drug engineered to cross the blood-brain barrier and attack the unique biology of glioblastoma tumors. Now in clinical trials, the therapy has already shown promising early signs in patients with advanced disease. Check out David's video. He talks about how flying "removes the constraints from daily life. It requires immense discipline and focus, which is kinda meditative. Up here in the clouds, I'm able to gain new perspective on things I'm going through, even research challenges in the lab." #healthcareinnovation #uclahealth https://lnkd.in/g_8gqYny UCLA Anderson School of Management UCLA Anderson Healthcare Business Association (HBA) UCLA Healthcare Alumni of Anderson Jodie Lesh Elisa Long